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7.1 Summary and discussion
Th e rise of small-animal image-guided precision radiotherapy platforms 
has been revolutionizing translational and radiobiological research. 
Modern devices and current advanced tumour models have enabled 
fundamental research on irradiation protocols, fractionation regimens, 
adjuvant therapies and established concepts in controlled environments, 
with large (transgenic) animal cohorts and accelerated results. A number 
of biological, physical and technological concerns remain. A recent 
report from the European society for radiotherapy and oncology advisory 
committee in radiation oncology practice (ESTRO ACROP) numbered 
the main challenges to be addressed in this fi eld[1]; it enquires about: 
- the key technologies for downscaling clinical treatments and 
the imaging modalities to be integrated and potentially used in 
treatment planning;
- the treatment of target motion and optimal irradiation margins;
- the accuracy and precision of small fi eld dosimetry and dose 
distribution verifi cation;
- the diff erence between high and low-energy photon irradiation.
Although categorized into diff erent topics, the challenges have a synergetic 
relationship: imaging requires sub-millimetric resolution, aff ects dosimetry 
and is aff ected by motion; and pre-clinically mimicking clinical scenarios 
requires lower energies to avoid large beam penumbras and dose (re-)buildup 
regions which also aff ect dosimetry and might yield diff erent treatment 
outcomes if dose calculations do not consider medium heterogeneities. 
Th is thesis has briefl y introduced the historical evolution of radiotherapy 
and the need for pre-clinical EBRT research (Chapter 1). It presented ways 
to tackle some of these challenges and warned about their drawbacks. In 
the following sections, the research concerning these and additional points 
is summarized, discussed and future perspectives from discussion points 
are canvassed.
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7.1.1 Imaging and dose calculations
In a framework to establish imaging protocols that allow accurate dose 
calculations, Chapter 2 examined the feasibility of using dual energy CT 
(DECT) to extract tissue atomic compositions and assess dose calculation 
accuracy gain. Th e study demonstrated improved accuracy for DECT in 
comparison to SECT. It stressed the arbitrariness of the broadly used SECT 
method: it is not clear which media and how many linear segments should 
be used for generating a calibration curve, and where to place material 
boundaries. Th e latter are oft en selected based on visual inspection, yielding 
inter-individual diff erences. In this study, three main deba table topics were 
analysed: tissue compositions, energy dependence and image quality.
Segmenting a specimen using only a single dense bone material with 
elevated eff ective atomic number caused high absorption, resulted in less 
photoelectric interactions in soft  tissue, higher dose deposition in osseous 
tissues and underestimation in the organs at risk (OARs) in proximity 
of bone. On the other hand, the choice of multiple bone types, using 
DECT, resulted in lower dose values for the diff erent tissues occupying 
the same volume and minimal assignment of (human) cortical bone (1.9%). 
It was recommended to segment mice using bony tissues with decreased 
density and eff ective atomic number values considering that their bones 
are fl exible and possibly closer to human cartilage in composition. 
Additionally, incorrect material segmentation was shown to be agg ravated 
with a decrease in beam energy due to the intensifi ed role of photoelectric 
cross-sections, causing materials with diff erent eff ective atomic numbers 
to absorb increasingly diff erent fractions of energy. Th ese two subjects, 
energy dependence and tissue compositions, are echoed throughout this 
thesis and have a deterministic relationship in this fi eld. 
Although necessary for MC dose calculations, tissue compositions have a 
marginal impact on clinical EBRT photon treatments, where incoherent 
interactions are predominant and dependent on tissue electron density[2]. 
Th eir infl uence is higher on clinical proton EBRT and kV techniques such 
as brachytherapy and small animal radiotherapy. For clinical protons 
beams, they infl uence the mean excitation energy used to calculate the 
proton stopping power ratio and aff ect range verifi cation techniques. 
For kV techniques, although Compton interactions are still important, 
photoelectric probability is signifi cant and this eff ect is strongly dependent 
on the atomic number of the medium (Z3  ̴4). Th e mass-energy absorption 
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coeffi  cients, a quantity closely related to absorbed dose, may diff er by more 
than a factor of six for low energies[3]. 
Th e assignment of tissue compositions is a bottleneck in radiotherapy. In 
pre-clinical EBRT, human tissue compositions are predominantly used 
due to the scarce literature on animal ones. A small number of studies 
has presented quantitative data on animal tissues[4-9], albeit unspecifi c for 
radiotherapy or focused on trace-elements. Th e increased biological interest 
on molecular or cellular entities rather than atomic ones and the practical 
diffi  culties in establishing atomic compositions are possible culprits. 
Clinical radiotherapy uses human tissue reference data listed in reports 46 
of the International Commission on Radiation Units and Measurements 
(ICRU) and report 23 from the International Commission on Radiological 
Protection (ICRP) [10-12].
Mann-Krzisnik has published a thorough study, which describes how the 
human reference data was established[13]. It reports that measurements were 
taken between 1940 and 1960. Lighter elemental composition (hydrogen, 
carbon, nitrogen and oxygen) was extrapolated from gross proportions 
of water, fat, proteins and carbohydrates while heavier elements were 
derived from spectrographic analysis of ashed and dried tissue samples 
extracted from cadavers. A number of issues was observed, e.g. some tissue 
compositions did not sum up to 100% or did not contain carbon, which is 
considered impossible for a biological tissue. Data was later rendered by 
several sources and renormalized, which may have added inconsistencies 
as individual studies started from diff erent premises (e.g. distinct levels 
of hydration or manipulation methods). Additionally, lighter elemental 
composition derivations may have neglected variations in chemical 
composition of fats, proteins and carbohydrates and the method employed 
for heavier elements possibly lacked precision. All measurements were 
derived from ex vivo samples, which might diff er from in vivo ones in terms 
of tissue compositions, hydration and densities. Moreover, akin to elemental 
composition, ICRU and ICRP density reference data is connected to the 
same studies, rendered from several publications and prone to similar 
issues. Diff erent from elemental compositions, density is typically derived 
from CT scans rather than reference data, hence the importance of this 
reference parameter is decreased.
Dosimetric implications of using human tissue compositions in mice 
have been investigated with DECT and diff erences between human and 
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murine elemental compositions led to dose errors of up to 20.1% for bones 
in addition to a large spread in mass-energy absorption coeffi  cients for 
diff erent tissues[14]. Th ese results stress the need of research on reference 
data or, minimally, establishing a relationship between human and animal 
tissues; for murine studies (and for other specimens used for radiotherapy 
research), population samples should include diff erent strains, genders 
and ages as concentration of certain elements vary within these categories. 
Moreover, the large spreads indicate that assigning one mean reference value 
to a whole organ is not realistic as there is a distribution of compositions. 
New technologies should be explored to derive updated quantities both in 
invasive and non-invasive ways. Th is topic is revisited in section 7.2.1.
Finally, Chapter 1 raised an image quality discussion motivated by extensive 
artefacts and noise on the CT scans. For the former, partial volume eff ects 
can explain the high source of errors on the boundary regions. For the 
latter, rather than uniform, the bulk of the phantom displayed a texture-
like appearance, with irregular CT numbers (42±62 and 16±57 HU for 50 
and 90 kVp scans) possibly due to noise; moreover the DECT material 
image, eff ective atomic number (Z
eff 
) image, was noisy and presented a 
mean Z
eff 
-value encompassing several soft  tissues (mean of 8.0±0.4, ranging 
from 6.0 to 10.7). As the CT projections were reconstructed with a simple 
Feldkamp-Davis-Kress (FDK) back-projection algorithm, it was presumed 
that the usage of iterative reconstruction algorithms with artefact 
correction kernels could improve the eff ect of noise and provide superior 
DECT material segmentation.
7.1.2 Iterative methods for image reconstruction
To analyse the eff ect of diff erent image reconstruction techniques on image 
quality and DECT metrics, Chapter 3 presented a soft ware platform for 
pre-clinical CBCT image reconstruction. Pre-processed projections were 
reconstructed using the analytical fi ltered back-projection (FDK) or the 
iterative reconstruction (IR) algorithms, e.g. iterative FDK, simultaneous 
algebraic reconstruction technique (SART), simultaneous iterative 
reconstruction technique (SIRT) or Conjugate Gradient (CG). A cupping 
correction was included, a polynomial pre-correction to the attenuation 
data for linearization. Imaging metrics were quantitatively assessed with a 
quality assurance phantom and DECT analysis was performed to determine 
the infl uence of each reconstruction technique on the relative electron 
density (ρe) and Zeff  values. 
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IR methods proved computationally costly due to the large matrices and 
small pixel sizes chosen for the study but presented satisfactory results with 
smaller grids, typical of pre-clinical practice. Nevertheless, reconstruction 
times were longer when compared to analytical methods as these algorithms 
use multiple repetitions. With increased computational power and the use 
of graphical processing units (GPUs), both with current technology, this 
diff erence can become negligible and not represent a limiting factor for 
online iterative reconstruction: time is of the essence in this fi eld as animals 
are imaged while restrained under sedation and long anaesthesia times 
might impair the fi tness of the specimen and the integrity of the study; this 
topic is further discussed in section 7.2.2. 
Th e cupping artefact correction provided accurate CT numbers and 
could benefi t larger subjects and applications that require increased 
image accuracy. Th e workfl ow needs improvement, as reconstructing an 
object a number of times to derive a polynomial, which will correct a 
fi nal reconstruction, is a lengthy and impractical process. Either a fi xed 
polynomial order could be chosen in advance according to the object size 
or diff erent algorithms could be applied. Regarding DECT, IR showed 
signifi cantly smaller spread for each material in the ρe-Zeff  space and lower 
Z
eff 
 and ρe residuals (on average 24% and 25% lower, respectively). Th is is an 
important result as it indicates that imaging noise was reduced and the IR 
methods provided tissue composition distributions closer to the reference 
values. Th us, IR could benefi t DECT tissue segmentation as the spread in 
ρe-Zeff  space could be closer to the spread in tissue values, and less aff ected 
by errors intrinsic to the imaging modality. A myriad of iterative methods 
exists and provide diff erent degrees of accuracy and computational times. 
Th is study showed the development of the soft ware and a fi rst application 
to small animal CBCT. Other algorithms, and back-projection, forward-
projection and window type fi lters, already foreseen in the soft ware, 
should be further characterized and additional artefact kernels further 
implemented to expand the reach of these techniques.
Considering the image quality aspect, the analysed reconstruction 
techniques provided acceptable and similar geometric accuracy, uniformity 
and CT number results. SART provided improved contrast-to-noise ratio 
(CNR) but lower resolution for some media, when compared to the other 
techniques. Accuracy on image metrics is crucial for dose calculations, as 
the contours of anatomical structures can suff er from reduced resolution, 
abundance of noise or non-uniformity. Geometric accuracy and contrast 
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are also important for spatial targeting and measurements of anatomical 
structures, which can determine how a tumour or an OAR is responding 
to treatment. Th e infl uence of the scanning parameters in terms of 
current, frame rate, rotational speed, gain and exposure were adopted 
from established protocols and could be revisited. It would be benefi cial 
to investigate if lower exposure times associated with IR methods would 
present similar CNR and noise levels at lower imaging doses. High imaging 
doses from cumulative scans may change the animal immune response and 
other biological pathways that may alter the experimental outcome[15-17]. 
Th us, quantifi cation of imaging dose is an important part of system 
commissioning and operation, especially for longitudinal studies. Th e use 
of imaging techniques that provide no radiation dose is also advised, when 
possible. 
Furthermore, an image quality assurance (QA) program should be in eff ect, 
following guidelines, which should provide tolerances for normal operation 
tests, and take corrective actions such as imaging system recalibration if 
tolerance levels are not met when recommended imaging protocols are 
used. Th e QA tests should happen periodically. Currently, due to the lack of 
specifi c recommendations, several research institutions have diff erent QA 
approaches, ranging from extensive tests to the absence of this practice. Th e 
4th Conference on Small Animal Precision Image-Guided Radiotherapy, 
Lisbon, March 2018, held discussions concerning this topic. Several experts 
agreed on the need for recommendations and that meanwhile users should 
design ways to ensure the calibration of their systems. It is possible to 
fi nd publications with acceptable QA tests[18, 19]. Beyond imaging, the QA 
program should also include the dosimetry of system, on an annual basis, 
to estimate the dose rate of the x-ray tube, using an appropriate ionization 
chamber and correction factors. Following the American Association of 
Physicists in Medicine (AAPM) Radiation Th erapy Committee Task Group 
61[20], or similar recommendations[21-23], for reference dosimetry of low- and 
medium energy x rays for radiotherapy and radiobiology. 
7.1.3 Irradiation margins
As mentioned on section 7.1, the treatment of target motion and optimal 
irradiation margins constitutes a challenge for small animal EBRT. In 
an attempt to confront these issues, the research presented in Chapter 4 
analysed the eff ect of respiratory motion on irradiation margins for murine 
lung tumours. Four-dimensional (4D) mathematical phantoms with 
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diff erent lung tumour locations and extreme breathing curves were used 
for dose calculations of a 360° arc treatment plan. A time-resolved dose 
was derived, considering the irradiator gantry rotation and the breathing 
motion. From diff erent radiotherapy metrics, it was understood that the 
eff ect of respiratory motion is dependent on the breathing pattern and 
the tumour position. Ultimately, a recipe, which considers the irradiation 
collimator size, was proposed to derive tumour margins and spare OARs 
by respecting constraints on user-defi ned metrics. Moreover, the addition 
of a target margin, especially on sites where movement is substantial, was 
recommended. 
Extreme breathing scenarios were used to represent the possible range 
where the actual breathing pattern would fall. It varies according to the 
anaesthesia protocol and the respiratory and cardiac rates. A sedation 
scenario with minimal motion while physically restraining the specimen 
is ideal. Th is study generated a few recommendations to avoid sub-optimal 
pulmonary treatments. Regarding the orthotopic tumour implantation, 
when possible, it is recommended to avoid the diaphragm region, as it is the 
region most aff ected by motion. Implantations on the superior lobe of the 
right lung are advised, as the left  lung is closer to the heart, an important 
OAR. Th e use of motion tracking and gating techniques for imaging and 
irradiation allow physiological heart and lung motion to have a decreased 
impact on imaging artefacts and dose heterogeneities [24, 25]. 
Diff erent gating approaches have been documented and rely on the type of 
scanner, the specimen and the research in question. In prospective gating, 
data acquisition is trigg ered by a motion signal. Prospective methods are 
used in scanners that operate under step-and-shoot conditions. Th e x-ray 
tube is trigg ered by a user-supplied signal based on the animal physiological 
motion. Respiratory and cardiac trigg er signals can be generated, e.g., 
with a mechanical ventilator at a selected point in the respiratory cycle, 
from real-time measurements of a pneumatic cushion positioned on the 
diaphragm, optical measurements of diaphragm motion, measurements of 
the heart rate or electrocardiogram (ECG) signal[26-33]. Retrospective gating 
is performed continuously and all motion correction is applied during 
post-processing. It can be performed both under continuous rotation or in 
step-and-shoot mode. Projection images and cardiac and respiratory signals 
are simultaneously and uninterruptedly recorded. Post-processing includes 
projection sorting based on the recorded physiological phase of the animal 
at the time each projection was acquired. Projections acquired in the same 
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phase are reconstructed[34-36]. Image-based gating determines the portion of 
the breathing or cardiac cycle in the projection space[37-39]. Diff erent x-ray 
shutter subsystems have been developed for both commercially available 
small animal irradiators[40-42], although only one subsystem is in commercial 
stage. Th ey allow beam gating during treatment, with irradiation only taking 
place during the breathing cycle when tissue movement is minimal. Th ey 
facilitate dose delivery during animal movement and are particularly well 
suited for irradiation of targets within the chest and abdomen. Although 
not used for the research of Chapter 3, gating techniques contribute to the 
treatment conformality and are likely to be implemented in most precision 
irradiators in the near future.
Finally, the use of margins is recommended. Th is study used a cost function 
based on dose-volume histogram (DVH) parameters and the available 
collimators. However, the recipe can be adapted according to adjustable 
constraints or collimation devices and is independent of the breathing curve; 
it could be applied for other respiratory or irradiation regimens. A thorough 
recipe for establishing the concept of planning target volume (PTV) should 
consider additional parameters such as setup and fractionation errors, 
when applicable. An important conclusion from this study is the need of 
considering anatomical and physiological characteristics during clinical 
to pre-clinical translation, or vice-versa. Although margins are sometimes 
extrapolated from clinical experience, they might not be representative for 
certain small animals. 
Independently of the margin function, the investigation of an interpolation 
function for dose accumulation from diff erent anatomic phases to a 
reference phase using a rigid grid (direct dose mapping) was proposed for 
speeding up the dose calculation process, as a fi rst approximation: tissue 
deformation and the cardiac motion were not modelled. Calculation 
times at least 10 times faster are promising for further development of the 
technique. However, results may depend on the targeted site and surrounding 
anatomy. Moreover, as the fi rst time point was considered the reference 
phase, the dose map derived from the CBCT scan could be subject to noise 
and blurring. Th is point was investigated through simulation of the full 
breathing cycle and eff ect of respiratory motion on the CT scan blurring 
was considered minimal while tumour shape was highly preserved. Th e 
presented technique could potentially be used for adaptive radiotherapy, 
which may require the daily delivered dose to be accumulated.
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7.1.4 Dose reporting
Another topic highlighted by the ESTRO ACROP report, mentioned in 
section 7.1, is the treatment (or lack thereof) of diff erent dose reporting 
quantities generated by the various dose calculation algorithms. 
Conventional and rather simpler dose calculations methods, which 
considered the human body as water-equivalent and reported dose to water, 
have evolved towards sophisticated model-based algorithms e.g. MC. Th e 
latter transports radiation through heterogeneous media and report the 
absorbed dose to a reference medium embedded in a surrounding transport 
medium. Diff erent dose reporting quantities have been derived using the 
cavity theory: they are dose-to-medium-in-medium (Dmm), dose-to-water-in-
medium (Dwm) or dose-to-water-in-water (Dww), which acknowledge the dose 
scoring and the surrounding media as arbitrary or water. Th ese quantities 
coexist to date and it is debatable which one to favour in detriment of the 
other. While Dmm is more likely to correlate with biological response, clinical 
experience on tumour, healthy tissue response and dosimetry protocols were 
built on Dwm. Moreover, changing between quantities may yield an additional 
level of uncertainty.
Th e study presented in Chapter 5 analysed the relationship between Dwm and Dmm 
on small animal irradiation energies, considering the dependence of Dwm with 
the dose calculation approach using the intermediate cavity theory (ICT). ICT 
corresponds to a sum of small (SCT) and large (LCT) cavity theory contributions 
weighted by the parameter d. In other words, it is the weighted sum of electronic 
stopping power (SCT) and mass-energy coeffi  cient (LCT) ratios between medium 
and water,                   Th e parameter d was calculated using two 
diff erent methods, which considered the exponential attenuation of primary 
electrons as they enter a cavity with secondary particle transmission of 1%[43] 
or 4%[44]. A set of mathematical phantoms was designed with diff erent voxel 
sizes, considering the pre-clinical practice and extreme scenarios, and a 
selection of materials, broad enough to include the range of densities and 
elemental compositions conventionally used in radiotherapy, as well as an 
ex vivo mouse chest case with highly heterogeneous regions were included. 
Local photon spectra were generated in diff erent regions of the chest case. 
Depending on the energy and the size of the cavity, Dmm presented lower or 
higher values, a factor of 0.68 to 4.37 times Dwm. 
ref
m[μen/ρ]
w
m(Sel/ρ) and .
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For soft  tissues, except adipose, the relationship between reporting 
quantities was found equal or close to unity for all diff erent scenarios, an 
expected behaviour in consequence of the similarities in terms of atomic 
composition and density amongst the media and water, and small cross 
section variations. Results for adipose and bony tissues diff ered as their 
composition diverges from water. For larger cavities, where the range of 
secondary particles is smaller or comparable to the cavity dimensions, and 
for lower energies, where the predominance of photoelectric interactions 
is increased and highly dependent on the tissue-equivalent material 
compositions, the diff erence between dose descriptors was amplifi ed. Hence, 
the impact of the cavity dimensions on estimated Dwm was signifi cant on 
pre-clinical kilovolt beams up to 225 kVp. Diff erences up to 5.1% were found 
between Dmm⁄Dwm  ratios, calculated using the local spectrum on diff erent 
regions within the chest case. Th erefore, the application of one single 
conversion factor between quantities for the whole phantom might not 
be appropriate. Large diff erences on d values between the two d-deriving 
methods implied that one should be cautious when using the ICT as there 
is a lack of consensus on which method to use. Further simulations and 
measurements, explicitly tracking secondary particles are recommended 
for establishing a global ICT. Th e abiding debate over which quantity to 
favour is foreseen to linger while it is not clear which quantity correlates 
better with the biological eff ects of ionizing irradiation; this topic will be 
revisited in section 7.2.4. Finally, dose distribution comparisons should use 
the same reporting quantity and caution regarding reported quantity and 
dose comparisons is advised.
Cavity theory was originally proposed for the determination of absorbed dose 
in the sensitive volume (a cavity) of a detector, e.g. an ionization chamber. 
Th e conversion of absorbed dose in an air-fi lled cavity to absorbed dose in 
water was formulated by Bragg  in 1912 and Gray in 1936 and later revisited by 
Spencer, Attix and Burch in 1955 and Nahum in 1978[45-50]. Th e conditions of 
the Bragg –Gray (BG) theory with Spencer–Attix–Nahum stopping-power 
ratios formed the basis of radiation dosimetry protocols widely adopted 
to MV photon and electron beams[51, 52]. If the dimensions of a cavity are 
large relative to the range of secondary electrons e.g. for low energy kV 
beams, the BG conditions do not hold, and the mass-energy absorption 
coeffi  cient ratios for cavity and medium are normally used. Although 
several other formalisms were proposed[53-56], including the weighted sum 
used in Chapter 5, their application remained marginal as treatments with 
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kV energies are not mainstream and MC methods emerged as a solution 
to the radiation transport problem allowing accurate estimation of the 
electron spectra within media. Revisiting this topic, regardless of powerful 
MC codes that calculate energy deposition in heterogeneous media, has 
two main justifi cations. First, not all small animal dose calculation engines 
use MC models to calculate Dmm: some algorithms
[57-59] calculate Dwmand use 
conversion factors to Dmm. Secondly, besides dose to a water voxel (or a 
voxel composed of water-like tissue) in medium Dwm has been extrapolated 
to a biological representation of the target where energy is deposited 
within an organism, such as DNA-bound water molecules or a subcellular 
compartment whose elemental composition is closer to water than medium. 
As Dwm depends on the cavity size, the signifi cance the water cavity size in 
relation biological eff ects becomes of interest. 
Th e cellular eff ects of radiation are not completely understood and the 
defi nition of radiobiological target has changed over time. Goodhead[60] 
indicated that microdosimetry theories have presented putative targets on 
the scale of 1 nm up to several μm. Th e current evidence points to 3–10 
nm (initial DNA damage), 0.1–0.5 μm (subsequent interactions), ≈10 μm 
(intracellular non-targeted eff ects) and millimetres or more (inter-cellular 
bystander eff ects and infl uences of the tissue microenvironment)[60]. 
Detailed track-structure simulations have assumed targets of 10–30 nm, 
the DNA molecule dimensions and extra space for free radicals released 
in water, and have correlated a quantity corresponding to linear energy 
transfer (LET) with RBE[61, 62]. Enger et al.[63] assumed μm-sized cell nuclei as 
the most important quantity with respect to biological eff ects and Th omson 
et al.[64] showed that doses to μm-sized targets depend on the composition 
and geometry of surrounding structures. Oliver and Th omson[65, 66] found 
that Dmm in small volumes (≈10 μm) is dependent on the composition and 
structure of the surrounding media, potentially rendering Dwm clinically 
meaningless until the eff ects of tissue composition are better understood.
Beyond the dose-reporting quantities currently employed, and besides 
their proportional relationship with biological eff ects, radiotherapy 
treatments and fundamental radiation knowledge could benefi t from 
a quantity more tightly related to RBE, e.g. cell death probability, 
biological endpoint or treatment outcome, rather than radiation dose[67, 
68]. From radiobiological and physical perspectives, as a number of factors 
infl uence the eff ect of radiation on cell-death (e.g. cell and radiation type, 
oxygenation, tissue composition, etc) it is important to understand their 
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underlying relationships to be able to consider their collective impact in 
a clinical setting. Although in vitro testing can provide some insight, the 
dynamic biological characteristics of a complex living organism require 
well designed pre-clinical experiments to separate eff ects; this topic will be 
revisited in section 7.2.4. 
7.1.5 Proton beam irradiation
In a venture into the light ion irradiation world, Chapter 6 presented an 
investigation on the capabilities of a clinical proton system, which features 
a unique adaptive aperture (AA), concerning the generations of fi elds 
small enough for pre-clinical in vivo irradiations. Th e in silico research 
was developed through a MC model of the proton beam line nozzle, which 
consists of an energy modulation system (EMS) and an AA. Th e EMS 
enables the 230 MeV beam nominal range to be decreased in multiples 
of 2.1 mm and the AA allows irradiation fi elds as small as 5 x 1 mm2. 
Irradiation treatment plans were tested with a set of discrete energies, 
fi eld sizes and beam directions, later compared to photon plans. Although 
the number of protons which hit the target drops to 1-3%, treatment 
times below fi ve seconds were found, with good tumour coverage and less 
damage to the OARs than in photon plans. Th is study contributed to a 
deeper understanding of the implications regarding the degradation of the 
nominal 230 MeV proton beam to low energies, the eff ect on spot size, dose 
homogeneity and dose rate. 
Proton treatments in Chapter 6 were designed either using low energy 
fi elds that stop in the tumour or high energy beams to shoot through. Th e 
former allows for a decrease in dose to healthy tissues and might be used to 
study RBE eff ects. Th e latter could be used for small animal proton imaging, 
for pre-treatment position verifi cation or to improve range uncertainty 
by directly measuring the animal relative stopping power maps. Th ese 
two topics will be readdressed in section 7.2.4. Th e EMS, characterized 
by a constant range stragg ling at the Bragg  peak, poses a disadvantage 
for pre-clinical research: it prevents an easy production of sharp beams. 
Furthermore, it presents an increase in lateral beam spot size for decreasing 
energies caused by the many plates in front of the beam. Although the 
AA collimates the beam, there is an intrinsic loss in effi  ciency when using 
large spot sizes with small fi elds: the beam is mostly absorbed by the AA. 
Th e intensity is also decreased in the central beam axis, as small angular 
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defl ections in proton trajectories are not negligible for small fi elds. 
Pre-clinical studies are important means to understand the radiobiological 
properties of ion therapies to eff ectively realize their potential benefi ts. 
Although some aspects, such as the eff ects of cell survival and proliferation-
based RBE values, have been well documented[69], there is a lack of in vivo 
studies. Th ey could be useful for diff erent radiobiological hypothesis, 
e.g. RBE dependence on fractionation, diff erential immune eff ects with 
respect to photon beams[70, 71] or, more generally, biological dependence 
on high LET. Ford et al.[72] have pointed out that irradiation technologies 
to study these eff ects are underdeveloped and that there is an urgent 
need for high-precision image-guided proton radiation delivery systems 
relevant to animal models. Currently, there are 158 clinical ion beam 
centres in operation, construction or planning stage[73]. Due to the high cost 
associated with these facilities, dedicated small animal ion beam systems 
are unlikely to be developed to a same extent as the photon beam ones. Th e 
proper adaptation of clinical facilities for small specimens, including image 
guidance, fi ts ideally into this context. However, challenges are expected, 
such as the acquisition of beam time in the clinical environment. 
7.2 Future perspectives
7.2.1 Tissue compositions
As emphasized in section 7.1.1, tissue elemental composition reference 
data, heavily used on clinical and pre-clinical dose calculations, are based 
on a few dated studies. Novel estimation techniques could potentially 
increase accuracy and add information on diff erent populations, gender 
and age. Th e non-destructive techniques particle induced x- and gamma-
ray emission (PIXE and PIGE) have been sugg ested to be complementary 
used to detect heavy element trace quantities and the mass proportions 
of the lighter ones, respectively. In both approaches, charged particles are 
accelerated towards a sample of interest: they may cause ionizations and 
subsequent x-ray emissions, PIXE, or, they may interact with nuclei within 
the sample and cause gamma-ray emissions, PIGE. Detection of these 
emissions may reveal the elemental composition of a sample. Additionally, 
destructive analytical methods include chromatography combined 
with mass spectrometry, infrared spectroscopy or thermal conductivity 
detection[13]. Other techniques ex vivo such as neutron activation analysis, 
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laser-induced breakdown spectroscopy (LIBS), secondary ion mass 
spectrometry (NanoSIMS), laser ablation-inductively coupled plasma mass 
spectrometry (LA-ICP-MS) have all been used for elemental composition 
analysis in diff erent scopes[74, 75].
In vivo techniques can facilitate tissue identifi cation, based on individualized 
data acquisition instead of reference data. Th ere is a multitude of techniques 
for composition estimation, divided into levels of increasing complexity: 
atomic, molecular, cellular, tissue system, and whole body[76]. Th ey range 
from simple skinfold measurements to bioimpedance analysis, dual energy 
x-ray absorptiometry, MRI, DECT and in vivo neutron activation analysis 
(IVNA) methods, such as delayed-γ, prompt-γ and inelastic neutron 
scattering. In IVNA methods, a subject is placed in a neutron fi eld, its 
atoms might undergo nuclear reactions and release gamma rays, which 
are simultaneously measured by scintillation detectors and correlated to 
elements. Although IVNA measures whole-body compositions, tissue values 
can be extrapolated through empirical rules. DECT and MRI methods are 
more convenient and available on an individual basis and yield lower or 
no radiation dose. Th e DECT principle is mentioned in Chapter 2. MRI is 
based on the interaction between hydrogen nuclei (protons) and magnetic 
fi elds. Briefl y, during a scan, protons absorb energy due to radiofrequency 
(RF) and release the absorbed energy when RF is ceased: the time it takes 
for protons to return to their original positions, dependent on interactions 
with the surrounding medium, can be exploited to yield diff erences between 
tissues.
Validation phantoms, human and animal studies for DECT and MRI 
have been compared to ex vivo data and showed good overall agreement 
within a distribution[77-82]. Th ese studies support the validity of tissue level 
estimates and may be considered in vivo reference standards[83]. Yet, there 
are many sources of uncertainty, such as instrument calibration, stability, 
subject participation and observer variation. Infl uence of image quality 
parameters also play an important role. Aft er the contribution of these 
factors is weighted, a distribution of values for diff erent tissues and organs 
is more likely to represent anatomical structures rather than a unique mean 
value, producing a sound representation of tissue heterogeneity, closer to 
reality. It would be rather advantageous to adapt MC calculations to spread 
out or clustered values.
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7.2.2 Image quality and dose
Section 7.1.2 showed that a myriad of imaging protocols and algorithms 
could be characterized to improve image quality and possibly add more 
value to DECT. However, the benefi ts would be rather small as current CT 
imaging technology has inherent limitations, which yield poor intrinsic 
and soft  tissue contrast. Although image quality is suffi  cient for skeletal 
topology, the application of contrast agents is typically necessary to visualize 
diff erences in soft  tissues. Th is practice has its caveats as it is associated 
with higher experimental complexity, larger cost and dose calculations 
eff ects. To overcome these limitations, relatively new semiconductor x-ray 
photon counting detectors are expected to bring CT imaging to a new 
technological generation. 
A number of photon counting detectors are commercially available 
(Medipix and Timepix[84], PILATUS[85], Eiger[86], XPAD[87] and PiXirad[88]) 
and include a large-area option[89] suitable for small animals[90]. Th ey operate 
diff erently from current scintillation-based systems, which detect x-ray 
photons indirectly through conversion into visible light and integrate the 
charge from the incoming photons, whereby high energy photons end up 
with a stronger weight than low energy ones. Th e semiconductor detectors 
process incoming photons at the pixel level as single events and weight all 
photons equally, thus off ering higher SNR. Th ey feature adjustable energy 
thresholds which allow counting incoming photons with dedicated energy 
for multispectral x-ray imaging. Th ey are practically noiseless and CNR 
is limited by the number of detected photons. Consequently, soft  tissue 
structures, with low diff erences in attenuation, can be visualised with high 
CNR[91]. Figure 7.1 shows images created this technology.
Moving towards this technology has been proven feasible[90] and would 
allow for the acquisition of improved information of morphological 
and structural changes of individual organs or tissue structures. It can 
provide multiple quantitative parameters for distinguishing malignant 
from benign tumours[92] and improve material analysis through the 
image-based extraction of tissue compositions, discussed in the previous 
section. Medipix detectors have been combined with mass spectrometry 
imaging to demonstrate spatial correlation of molecular and 3D structural 
information[93]. If used in place of DECT they can provide reduced motion 
artefacts and radiation doses, and would not require image registration. 
IR techniques should also be implemented for image reconstruction using 
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this technology. Currently, the lack of a commercial system developed with 
hardware and soft ware for these detectors, limit their scope to fundamental 
research and a few commercial applications. 
In addition to hardware, image reconstruction techniques are likely to 
undergo substantial developments. In Chapter 3, a soft ware platform for 
image reconstruction was presented. Briefl y, the soft ware received CBCT 
projections, encoded as an intermediate representation of the object in the 
detector domain, and reconstructed them into an image by the invertion of 
the encoding function. Analytically, it gradually solved the Radon inversion, 
and iteratively it used a cost function, which considered prior knowledge 
of projections or the image and noise properties. Image reconstruction 
is a challenging process: projections are acquired by imperfect and noisy 
detectors; iterative techniques have simplistic noise models and involve 
time-consuming steps. Artifi cial intelligence (AI) methods have been used 
for the entire image reconstruction process or to act on specifi c artefact 
and noise corrections.
Data-driven supervised learning frameworks have recently been proposed 
for image reconstruction. Th e automated transform by manifold 
approximation, AUTOMAP[94], learns a mapping between the detector and 
Figure 7.1 – (a) Image of a cockroach taken by the WidePIX detector. Th e zoom detail shows veins 
and a tick parasite in the inset. Reproduced with kind permission from Jakubek et al. 2014[89]. (b-d) 
Th e use of these detectors in artworks. (b) Th e painting of La Crau with a View of Montmajour, with 
the signature Vincent, was subject to material-sensitive X-ray radiography. (c) the fi gure of a female 
nude from behind was found underneath the painting, similar to other van Gogh works. (d) Th e X-ray 
images are able to show the distribution of individual pigments across the image and the way they were 
applied. Using energy channel separation to achieve individual layers and materials the materials that 
are only related to a target layer of paint become evident. Th is method allows a completely new way of 
working with X-ray radiography using advanced pixel detectors. 
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the image domain, derived from training data. It is implemented with a 
deep neural network, which learns diff erent reconstruction transforms for 
various imaging acquisition strategies, using similar network architecture 
and parameters. It generates images with reduced noise and artefacts when 
compared with conventional methods. As AUTOMAP does not handle large 
reconstruction matrices, the Radon inversion approximation, RAINAP[95], 
was proposed by a diff erent group. It represents a unifi ed framework 
for Radon inversion using neural networks. Th e algorithm fi rst applies 
fi ltering and back-projection operations with two learnable appropriative 
network layers to perform the domain transform. Subsequently, it uses a 
convolutional neural network to refi ne the reconstruction performance. 
Besides algorithms targeting the reconstruction problem, several deep 
learning methods, including neural networks have been proposed to act on 
image quality parameters. For example, deep learning techniques have been 
used to minimize the mean-squared error between an artifi cially denoised 
CT image and the ground truth under generic penalties[96]; denoising based 
on the generative adversarial networks, which focus on migrating the noise 
distribution from statistically strong to weak, have also been proposed[97] 
and convolutional neural network (CNN) or deep neural networks for 
sparse-view artefact reduction.
AI applied to medical imaging has been exponentially expanding and is 
likely to change several aspects of this fi eld[98, 99]: it is a suitable candidate for 
solving ill-posed inverse problems, and, as CT scans are routinely collected, 
large data sets are readily available. Current commercial soft ware does not 
treat image artefacts with machine learning (ML) techniques, although it is 
expected to happen in the near future, ML requires massive computational 
resources, including state-of-the-art GPUs for data training with adequate 
and representative data. Pre-clinically, it is expected to yield advantageous 
results as small animals share more similarities than humans. A proper 
image database is necessary and still represents a drawback as most research 
institutions lack an organized database. Machine learning techniques have 
also been proposed for noise reduction in low-dose CT, therefore reducing 
the subject imaging dose. 
Imaging dose is a concern and a potential limiting factor if successive 
CT scans would infl uence experimental outcome. Pre-clinical irradiators 
have recently been adapted to support bioluminescence imaging (BLI) 
integrated in the same frame of reference of the CT scanner. BLI is a type 
of molecular imaging, where a sensitive optical camera in a light-tight 
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environment records weak light sources originating up to a few centimetres 
deep in tissues[100]. It has a high signal-to-noise ratio, fast acquisition times, 
it is easy to use and cost-eff ective. Optical imaging has become increasingly 
attractive due to the availability of targeted probes, probes activated due 
to enzymatic reactions or probes that can be produced by cells themselves 
in the form of bioluminescent enzymes[101]. It does not present additional 
radiation burden to the animals and can be used to evaluate longitudinal 
tumour growth and to estimate tumour size. However, due to low spatial 
resolution, typically 1-2 mm, it is not suited for morphological and 
somewhat suited for functional imaging[102]. It generates a two-dimensional 
(2D) planar image. Recent eff orts have been put on 3D image reconstruction 
of this technique, which is also expected to benefi t from AI techniques[103].
7.2.3 From target margins to treatment adaptation
Th e research on target margins could spawn a couple of prospective 
studies. Firstly, the recipe described in Chapter 2 used DVH metrics to 
yield radiotherapy treatment margins. A thorough investigation on the 
radiosensitivity of diff erent murine OARs based on current irradiation 
technology, considering dose rates and dynamic treatments could promote 
margin recommendations for diff erent sites. And secondly, the eff ect of 
respiratory motion on the CT image blurring could be fully investigated 
through projection based 4D-CBCT simulation, using the MC code GATE, 
as it provides good capabilities for imaging simulation.
Another topic mentioned at the end of the discussion regarding Chapter 
4 was adaptive radiotherapy. A verifi cation system to quantify possible 
discrepancies between planned and delivered dose could bring extensive 
benefi ts to this fi eld. Discrepancies with respect to planned dose can occur 
due to motion between imaging and treatment and due to anatomical 
changes in the course of treatment. Th e clinical practice with photon 
beams has adapted the imaging panel, also called electronic portal imaging 
device (EPID), to be a verifi cation tool for diff erent scenarios: before, 
during or aft er treatment and with or without the subject present during 
the verifi cations. Th ere are four main scenarios [104] presented in Figure 7.2. 
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Treatment verifi cation implementation requires a framework for image 
prediction and comparison, fl uence back-projection, dose reconstruction 
and the conversion of image into dose. Furthermore, a number of 
measurements and calibrations are necessary to act on possible sources of 
errors inherent to the image detector, such as warm-up time, radiation dose 
history eff ect, stability and short- and long-term reproducibility, gantry 
angle dependency, output factor and response linearity. Other sources 
of dose delivery errors rely on operator- and system-related factors that 
can individually or cumulatively contribute to dosimetric errors, such 
as incorrect fi lter selection, gantry sag and wobble, couch rotation, and 
collimator misalignment. Pre-clinically, dose delivery has been investigated 
Figure 7.2 – Verifi cation scenarios: (a) detector level with subject: an image is acquired and compared to 
a pre-calculated one, based on the treatment plan; (b) at subject level with subject: the photon fl uence is 
measured at detector level aft er its passage through the subject and is back-projected upwards through 
the subject; an independent dose calculation is performed and the 3D reconstructed dose distribution is 
compared to the planned dose; (c) at detector level without subject: an image is acquired and compared 
to a pre-calculated one, errors related to the subject cannot be detected but it can be verifi ed if the 
planned image corresponds to the delivered one and (d) at subject level without subject: fl uence is back-
projected without the subject and photons are subsequently forward propagated for a dose calculation 
in the CT image, which is compared to the planned dose.
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using dosimeters, such as oxide semiconductor fi eld eff ect transistors 
(MOSFETs) surgically implanted in mice or Gafchromic fi lm for narrow 
kV beams[105, 106]. Regarding the use of EPIDSs, Granton et al.[107] investigated 
the accuracy of the treatment plan delivery using a MC model to simulate 
the fl at panel image. Simulation was compared to measurements to verify 
that intended treatment dose agreed with the delivered treatment dose. 
Dose delivery errors resulting from intrafraction motion were also assessed. 
Anvari et al.[108, 109] quantifi ed the dosimetric characterization of the EPID 
at kV x-ray energies in a year-long period and, in a subsequent study, they 
converted EPID images into 2D dose maps at the detector plane and used 
these maps to calculate 2D dose distribution at the exit surface in phantoms. 
Accuracy of transit and exit dose distributions were independently 
validated with ion chamber and fi lm measurements. Further development 
of these techniques, including 3D or 4D models could increase treatment 
conformity and add more value to the comparison with or the translation 
to clinical practice.
7.2.4 Dose reporting
Previously mentioned on section 7.1.5, the debate over which dose 
reporting quantity to favour in radiotherapy Dmm or Dwm lacks quantitative 
radiobiological data. Th is information could potentially establish which one 
best correlates with biological damage. Precise radiotherapy experiments 
on complex living systems have only recently become feasible through 
novel pre-clinical irradiation platforms. Considering the opportunity 
to investigate a fundamental scientifi c question on highly controlled 
experimental conditions, the most immediate future work following the 
discoveries of this thesis should be to investigate the infl uence of the 
physical aspects on cell death caused by radiation dose, particularly the 
impact of dose prescribed using diff erent quantities. A study protocol has 
been designed along with the radiobiology department. Th e aim is to analyse 
acute radiation eff ects from doses prescribed with Dmm and Dwm. Several 
essays are foreseen, e.g. clonogenic survival, gut toxicity, blood profi le and 
bone marrow leucocytes and lymphocytes. A range of kV energies should 
be applied, as RBE is expected to increase for lower energies, yet not 
excessively low as dose-rate eff ects should not interfere. Greater radiation 
damage diff erence is expected for lower energies. Gaining insight in this 
will provide essential data towards a fundamental understanding of how 
living tissue interacts with radiation.
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7.2.5 Light ions
Similar to photon platforms, clinically relevant pre-clinical proton research 
requires image guidance. Chapter 6 and section 7.1.5 showed the feasibility 
of a clinical set-up used pre-clinically and concluded that high energy beams 
can be used to shoot through the specimens and enable proton imaging or 
range verifi cation. Proton imaging typically off ers limited spatial resolution 
due to Coulomb scattering: on their way through matter, protons are slowed 
down in interactions with atomic electrons and defl ected from their initial 
direction in electromagnetic interactions with atomic nuclei, resulting in 
an angular spread from many defl ections. Sophisticated methods, such as 
single particle tracking or magnetic optics can improve image resolution[110]. 
Muller et al. sugg ested a method for dual-energy proton radiography using 
enhancement of residual energy distribution for diff erent proton energies. 
Th e images show structures dominated by energy absorption or scattering 
of protons in the object. Although their images lack spatial resolution, 
they are suffi  cient for position verifi cation, provide low imaging dose, use 
same frame of reference of the treatment beam and the absorption images 
allow range verifi cation within the animal. Th is technique can be further 
exploited into proton-CT imaging.
Chapter 6 also concluded that lower energy proton treatments, designed 
to stop at the tumour could be used to study RBE eff ects. In comparison 
to photons, light ion beams produce increased energy deposition with 
penetration depth and intensify biological eff ectiveness with enhanced 
ionization density in individual particle tracks, where DNA damage 
becomes clustered and more diffi  cult to repair. Radiobiological and 
biophysical studies have improved the RBE understanding of light ions 
and dose-localizing properties. However, in a recent review, Paganetti[111] 
has challenged the whole concept of the proton RBE value of 1.1. He 
considered it “generic, spatially invariant within tumours and normal 
tissues [which] disregards the evidence that proton RBE varies with LET, 
physiological and biological factors, and clinical endpoint”. He further 
analysed the relationship between RBE and dose, biological endpoint 
and physical properties of proton beams and concluded that there are 
considerable uncertainties in RBE values, where additional radiobiological 
data is necessary to reduce uncertainties to clinically acceptable levels. 
Besides uncertainties in RBE, proton treatments could benefi t from 
advanced research on fractionation schemes, radioresistance and adjuvant 
therapies[112]. 
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In parallel, there has been a crescent development of targeted 
radiopharmaceutical therapies using alpha, beta, Auger and positron 
emitters, due to a higher availability of isotope production. Here, instead 
of an external hadron beam, a pharmaceutical labelled with a radioisotope 
binds to specifi c target cells and may allow fatal dose delivery to malignant 
structures while sparing the majority of healthy tissue. For clinical feasibility, 
a radionuclide must have a suitable emission at a reasonable branching 
ratio, suitable chemical properties to allow attachment to relevant ligands 
and an appropriate half-life. Th is fi eld largely relies on pre-clinical research 
as a pipeline for phase I clinical trials and the dosimetry is heavily based 
on imaging, using functional techniques such as SPECT/CT, PET/CT and 
autoradiography. Especially for rare radionuclides, which show promising 
results in animal models, such as Actinum-225[113, 114] and Astatine-211[115], it 
should be advantageous to research the correlation of these new techniques 
with standard external beam irradiation regarding treatment outcome. 
Moreover, research on targeted radionuclide therapy as adjuvant technique 
can also be benefi cial.
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7.3 Final remarks
Regardless of the immense possibilities pre-clinical radiotherapy off ers, it is 
unavoidable to acknowledge that small animals are not humans. Frequently, 
their unique characteristics favour research, e.g. ability to manipulate 
their phenotype and genotype. However, the vast majority of studies are 
not replicated in humans[116]. In a recent review, Koontz et al.[117] pointed to 
some issues in successful pre-clinical translation to standard treatments, 
summarized in Table 7.1. Besides the diffi  culties in matching human and 
mice biology, radiation delivery and physical properties of the irradiators 
are oft en diff erent from the clinic. Considering strategies to increase 
pre-clinical research productivity, they encouraged the use of orthotopic 
models, biomarkers, pharmacodynamic read-outs, robust imaging and 
computational modelling. Th ey concluded that the selection of mice should 
favour “a direct bilateral link (…) to the molecular characteristics of the 
human condition and that of the appropriate mouse strain” and pre-clinical 
and clinical research should work as a cycle “considering the biology 
which needs to be represented in the model, tailoring the physics of the 
irradiation as close to the human situation as possible and acknowledging 
the limitations that cannot be overcome”. 
Finally, for successful pre-clinical research from physical and biological 
standpoints, the multidisciplinarity of this fi eld cannot be forsaken. 
Progress can only be achieved through the combined eff orts and wisdom 
inherent of diff erent fi elds. 
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Table 7.1 – Considerations with small animal radiotherapy models. Reproduced with kind permission 
from Koontz et al.[117]
CONCERNS EXPLANATION
biological
phys ical
Treatment naıve animals
Immune status
Inherent biology diff erences
Field Size
Radiation dose/
fractionation/dose rate
Irradiator energy 
diff erences
Animal setup
Radiation QA procedures
Mutational stress caused by heavily pre-treated human cancer
Immune system part of radiation response
Molecular biology diff erences between mouse and human
Dose accuracy
similarity to human anatomical borders
Radiobiology diff erences
kV planning soft ware for accurate dose prediction
OAR
Anesthesia: air mix
Frequency of testing
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